Robert Yeh's guest appearances

Robert Yeh

Interviews

The Accad and Koka Report

Elon Musk

Sally Satel

Terence Kealey

Adam Mortara

Damian Carabello

Martha Gulati

Geoffrey Rose

Paul Fine

Manny Sethi

George Delgado

Richard Menger

Tracy Høeg

Daniel Jafari

Paul Offit

Arthur Caplan

OwlTail

Our guest is Robert Yeh, Associate Professor of Medicine at Harvard Medical School and Director of the Smith Center for Outcomes Research in Cardiology at the Beth Israel Deaconess Medical Center in Boston. We discuss the challenges of outcomes research and his excellent work to improve the reliability of observational studies.SHOW NOTESRobert W. Yeh, MD: Twitter and professional web pageWatch the episode on YouTubeStrom JB, et al. Use of Administrative Claims Data to Assess Outcomes and Treatment Effects in Randomized Trials of Transcatheter Aortic Valve Replacement (in Circulation)Faridi KM, et al. Use of Administrative Claims Data to Estimate Treatment Effects for 30 days versus 12 months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention (in Circulation)Konstam M. Real World Data as trial End Points: Off and Running with a Long Way to Go (editorial in Circulation)Previous Guest Appearance: Ep. 19 Public Reporting: Necessary Evil or Harmful Fake News?

Our guest is Robert Yeh, Associate Professor of Medicine at Harvard Medical School and Director of the Smith Center for Outcomes Research in Cardiology at the Beth Israel Deaconess Medical Center in Boston. We discuss the challenges of outcomes research and his excellent work to improve the reliability of observational studies.SHOW NOTES Robert W. Yeh, MD: Twitter and professional web pageWatch the episode on YouTubeStrom JB, et al. Use of Administrative Claims Data to Assess Outcomes and Treatment Effects in Randomized Trials of Transcatheter Aortic Valve Replacement (in Circulation)Faridi KM, et al. Use of Administrative Claims Data to Estimate Treatment Effects for 30 days versus 12 months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention (in Circulation)Konstam M. Real World Data as trial End Points: Off and Running with a Long Way to Go (editorial in Circulation)Previous Guest Appearance: Ep. 19 Public Reporting: Necessary Evil or Harmful Fake News?

Robert Yeh on Harnessing Real World Evidence

Our guest is Robert Yeh, Associate Professor of Medicine at Harvard Medical School and Director of the Smith Center for Outcomes Research in Cardiology at the Beth Israel Deaconess Medical Center in Boston. We discuss the challenges of outcomes research and his excellent work to improve the reliability of observational studiesGUEST:Robert W. Yeh, MD: Twitter and professional web pageLINKS:Strom JB, et al. Use of Administrative Claims Data to Assess Outcomes and Treatment Effects in Randomized Trials of Transcatheter Aortic Valve Replacement (in Circulation)Faridi KM, et al. Use of Administrative Claims Data to Estimate Treatment Effects for 30 days versus 12 months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention (in Circulation)Konstam M. Real World Data as trial End Points: Off and Running with a Long Way to Go (editorial in Circulation)PREVIOUS GUEST APPEARANCE:Ep. 19 Public Reporting: Necessary Evil or Harmful Fake News?WATCH ON YOUTUBE:Watch the episode on our YouTube channelSUPPORT THE SHOW:Make a small donation on our Patreon page on and join our discussion group or receive a free book.

Our guest is Robert Yeh, Associate Professor of Medicine at Harvard Medical School and Director of the Smith Center for Outcomes Research in Cardiology at the Beth Israel Deaconess Medical Center in Boston. We discuss the challenges of outcomes research and his excellent work to improve the reliability of observational studiesGUEST:Robert W. Yeh, MD: <a href="https://twitter.com/rwyeh" rel="nofollow" target="_blank">Twitter</a> and <a href="https://connects.catalyst.harvard.edu/Profiles/display/Person/30625" rel="nofollow" target="_blank">professional web page</a>LINKS:<ul><li>Strom JB, et al. Use of Administrative Claims Data to Assess Outcomes and Treatment Effects in Randomized Trials of Transcatheter Aortic Valve Replacement (in <a href="https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.046159" rel="nofollow" target="_blank">Circulation</a>)</li><li>Faridi KM, et al. Use of Administrative Claims Data to Estimate Treatment Effects for 30 days versus 12 months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention (in <a href="https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.047729" rel="nofollow" target="_blank">Circulation</a>)</li><li>Konstam M. Real World Data as trial End Points: Off and Running with a Long Way to Go (editorial in <a href="https://www.ahajournals.org/doi/full/10.1161/CIRCULATIONAHA.120.048019" rel="nofollow" target="_blank">Circulation</a>)</li></ul>PREVIOUS GUEST APPEARANCE:<a href="https://accadandkoka.com/episodes/episode19/" rel="nofollow" target="_blank">Ep. 19 Public Reporting: Necessary Evil or Harmful Fake News?</a>WATCH ON YOUTUBE:<a href="https://youtu.be/2YvPg6_DTRo" rel="nofollow" target="_blank">Watch the episode</a> on our YouTube channelSUPPORT THE SHOW:<a href="https://www.patreon.com/accadandkoka" rel="nofollow" target="_blank">Make a small donation</a> on our Patreon page on and join our discussion group or receive a free book.

Ep. 142 Robert Yeh on Harnessing Real World Evidence